Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
Because the skin is constantly changing with age, the results of glutathione IV therapy are not permanent
the combination L-carnitine + L-lysine therefore has an increased activity (potentiating or synergistic effect) which can be explained by an increase in the bioavailability of L-carnitine, at the level of the target organs, muscles and myocardium
Medically reviewed by Charles Kamen, MD, board-certified neurologist Under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, the FDA decides which bulk drug substances a compounding pharmacy may legally use, and that list has shifted several times for peptides between 2023 and 2026